Novel therapeutic agents for relapsed classical Hodgkin lymphoma
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Haematology"
DOI: 10.1111/bjh.15695
Abstract: Hodgkin Lymphoma (HL) is a B‐cell lymphoproliferative disorder with an excellent prognosis for the majority of patients who are treated with multi‐agent chemotherapy, with or without radiation. A subset of patient, however, does not respond… read more here.
Keywords: lymphoma; relapsed classical; hodgkin lymphoma; agents relapsed ... See more keywords